The United States is helping some developing countries rework their drug patent laws in ways that "go beyond global standards" in protecting pharmaceutical companies and that could "undercut" President Bush's five-year, $15 billion AIDS initiative by making antiretroviral drugs more expensive and more difficult to obtain, the Wall Street Journal reports. "There are many ways that the Bush administration has contravened the letter and spirit of international efforts to improve access to drugs in developing countries,” Asia Russell, international policy coordinator at the Health GAP, said.